Towards first-in-class siRNA therapeutics for adrenal targets

Research unit

INNOSUISSE

Project number

134.630 IP-LS

Project title

Towards first-in-class siRNA therapeutics for adrenal targets

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	We aim to develop first-in-class siRNA drug candidates for adrenal targets using Procavea's proprietary, protein-based delivery platform. The pre-clinical data generated will serve to further validate the technology platform, bringing it closer to commercialization.